GOLDMAN SACHS GROUP INC

Holdings History for Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

Symbol: TRML
Investment type: Equity / Common stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0%	$0	0	-376,738	-100%	$47.98	Q4 2025
30 Sep 2025	0%	+0%	$18,019,379	376,738	+197,017	+110%	$47.83	Q3 2025
30 Jun 2025	0%	+0%	$2,873,738	179,721	+96,802	+117%	$15.99	Q2 2025
31 Mar 2025	0%	-0%	$1,261,198	82,919	-22,210		$15.21	Q1 2025
31 Dec 2024	0%	+0%	$2,132,016	105,129	+33,130	+46%	$20.28	Q4 2024
30 Sep 2024	0%	-0%	$1,851,095	71,999	-35,409	-33%	$25.71	Q3 2024
30 Jun 2024	0%	-0%	$1,381,267	107,408	-90,511	-46%	$12.86	Q2 2024
31 Mar 2024	0%	+0%	$4,532,345	197,919	+188,916	+2098%	$22.90	Q1 2024
31 Dec 2023	0%	+0%	$235,699	9,003	+9,003	NEW	$26.18	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.